Miranda Chakos

Medicine · Health Sciences

37h-index10.3kcitations86works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(57), Functional Brain Connectivity Studies(15), Bipolar Disorder and Treatment(14), Treatment of Major Depression(13), Advanced Neuroimaging Techniques and Applications(13)

Publications86 total

Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
UNC Libraries·2020· 1 citedOpen Access
Aggression and Quantitative MRI Measures of Caudate in Patients With Chronic Schizophrenia or Schizoaffective Disorder
UNC Libraries·2020Open Access
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
UNC Libraries·2020Open Access
Treatment of Acute Psychosis with Second-Generation Antipsychotics in a Patient with Left Temporal Lobe Lesion
Case Reports in Psychiatry·2018· 3 citedOpen Access
Safe Use of Atypical Antipsychotics in a Patient With Postpartum Psychosis and a History of Seronegative Myasthenia Gravis
The Primary Care Companion For CNS Disorders·2017· 3 cited
Concomitant Psychotropic Medication Use During Treatment of Schizophrenia Patients: Longitudinal Results from the CATIE Study
Clinical Schizophrenia & Related Psychoses·2011· 25 cited
Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
The Journal of Clinical Psychiatry·2010· 67 cited
BJP volume 193 issue 4 Cover and Front matter
The British Journal of Psychiatry·2008Open Access
Extrapyramidal side-effects of antipsychotics in a randomised trial
The British Journal of Psychiatry·2008· 266 citedOpen Access
Aggression and Quantitative MRI Measures of Caudate in Patients With Chronic Schizophrenia or Schizoaffective Disorder
Journal of Neuropsychiatry·2006· 45 citedOpen Access
Aggression and Quantitative MRI Measures of Caudate in Patients With Chronic Schizophrenia or Schizoaffective Disorder
Journal of Neuropsychiatry·2006· 37 cited
Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Psychiatric Services·2006· 111 cited
Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Psychiatric Services·2006· 117 cited
Catechol-O-methyltransferase and Monoamine Oxidase-A Polymorphisms and Treatment Response to Typical and Atypical Neuroleptics
Journal of Clinical Psychopharmacology·2006· 6 cited
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
Psychiatry Research Neuroimaging·2005· 87 citedOpen Access
Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
Schizophrenia Research·2005· 156 cited
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
Schizophrenia Research·2005· 210 cited
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
The British Journal of Psychiatry·2005· 140 citedOpen Access
Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia
The Journal of Clinical Psychiatry·2004· 71 cited
Premorbid Functioning in Schizophrenia: Relation to Baseline Symptoms, Treatment Response, and Medication Side Effects
Schizophrenia Bulletin·2004· 84 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jeffrey A. Lieberman(29), Brian Sheitman(22), Robert M. Bilder(15), Jan Volavka(14), Leslie Citrome(13), Joseph P. McEvoy(12), A. Koreen(11), Pál Czobor(11), Jean-Pierre Lindenmayer(10), José Alvir(8), David Mayerhoff(7), J.A. Lieberman(7), Thomas B. Cooper(7), Margaret G. Woerner(6), J.A. Lieberman(6), Matthew J. Hoptman(6), John M. Kane(6), Del D. Miller(6), Robert A. Rosenheck(6), Richard S.E. Keefe(6)